AbbVie (ABBV) Tops Q4 EPS by 4c, Raises FY18 EPS Guidance
Get Alerts ABBV Hot Sheet
Join SI Premium – FREE
AbbVie (NYSE: ABBV) reported Q4 EPS of $1.48, $0.04 better than the analyst estimate of $1.44. Revenue for the quarter came in at $7.74 billion versus the consensus estimate of $7.53 billion.
GUIDANCE:
AbbVie sees FY2018 EPS of $7.33-$7.43, versus the consensus of $6.59.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- ESSA Bancorp (ESSA) Tops Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!